13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 40 holding rows worth $183,369,836.
- Accession
- 0001420506-23-000529
- Filer
- CIK 1617201
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 40 entries on the cover page, a total value of $183,369,836 stated on the cover page (in dollars after the unit check, H1), rows summing to $183,369,836 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 465,000 | $20,636,700 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 330,000 | $19,882,500 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,754,429 | $12,351,180 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 1,633,546 | $10,650,720 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 486,726 | $10,518,149 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 90,000 | $10,242,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 341,521 | $8,923,944 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 17,253 | $8,836,814 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,180,000 | $6,950,200 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 308,776 | $6,021,132 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 858,709 | $5,976,615 | dollars as filed | |
| TRINET GROUP INC COM | 896288107 | Stock | 78,000 | $5,288,400 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P106 | COM | 1,840,510 | $5,245,454 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 2,113,493 | $4,861,034 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 154,898 | $4,660,881 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 50,000 | $4,283,500 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 621,667 | $4,202,469 | dollars as filed | |
| HEALTH CATALYST INC | 42225T107 | COM | 347,724 | $3,696,306 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 322,754 | $3,269,498 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 916,558 | $3,042,973 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 5,000 | $2,650,900 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 72,116 | $2,516,127 | dollars as filed | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 145,916 | $1,987,376 | dollars as filed | |
| OAK STR HEALTH INC | 67181A107 | COM | 84,000 | $1,806,840 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 463,310 | $1,779,110 | dollars as filed | |
| GALAPAGOS NV | 36315X901 | SPON ADR | 40,000 | $1,775,200 | dollars as filed | call |
| SEAGEN INC | 81181C904 | CALL | 12,000 | $1,542,120 | dollars as filed | call |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 289,335 | $1,429,315 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 116,732 | $1,340,083 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C957 | COM | 40,900 | $1,208,186 | dollars as filed | put |
| MORPHIC HLDG INC | 61775R105 | COM | 42,949 | $1,148,886 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 185,014 | $786,310 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 81,907 | $690,476 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 89,027 | $678,386 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 32,193 | $630,017 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 265,000 | $575,050 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 66,438 | $498,949 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 275,561 | $454,676 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 107,063 | $215,197 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 58,668 | $116,163 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000529 | this filing | 2023-02-14 | acceptance time not in the bulk data set |